Your browser doesn't support javascript.
loading
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers.
El-Kalyoubi, Samar; Khalifa, Mohamed M; Abo-Elfadl, Mahmoud T; El-Sayed, Ahmed A; Elkamhawy, Ahmed; Lee, Kyeong; Al-Karmalawy, Ahmed A.
Afiliação
  • El-Kalyoubi S; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Port Said University, Port Said, Egypt.
  • Khalifa MM; Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
  • Abo-Elfadl MT; Biochemistry Department, Biotechnology Research Institute, National Research Centre, Cairo, Egypt.
  • El-Sayed AA; Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Cairo, Egypt.
  • Elkamhawy A; Photochemistry Department, Chemical Industries Research Institute, National Research Centre, Giza, Egypt.
  • Lee K; College of Pharmacy, BK21 FOUR Team and Integrated Research Institute for Drug Development, Dongguk University-Seoul, Goyang, Republic of Korea.
  • Al-Karmalawy AA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
J Enzyme Inhib Med Chem ; 38(1): 2242714, 2023 Aug 17.
Article em En | MEDLINE | ID: mdl-37592917
A new wave of dual Topo I/II inhibitors was designed and synthesised via the hybridisation of spirooxindoles and pyrimidines.In situ selenium nanoparticles (SeNPs) for some derivatives were synthesised.Cytotoxicity, Topo I and Topo II inhibitory assays, and DNA intercalation abilities were evaluated.Compound 7d NPs showed the best Topo I and Topo II inhibition.Cell cycle arrest, apoptosis induction, and molecular docking studies were performed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Selênio / Nanopartículas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Selênio / Nanopartículas Idioma: En Ano de publicação: 2023 Tipo de documento: Article